Board of Sequent Scientific to sell stake in Strides Pharma Science to Promoter Group
Also approves acquisition of minority stake in Provet, Turkey
The Board of Sequent Scientific at its meeting held on 12 August 2020 has approved Sale of 33,12,500 shares of Strides Pharma Science , held by the Company to the existing Promoter Group of the Company. Further, the Board approved acquisition of minority stake in Provet Veteriner Urunleri San. VeTic. A.S (Provet), Turkey.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 12 2020 | 5:10 PM IST